The results from the ID93+GLA-SE TB vaccine clinical trial have just been published in the Lancet Respiratory Medicine journal. The candidate vaccine displayed an acceptable safety profile and provides encouraging evidence of vaccine-induced immune responses when given to cured TB patients at the end of treatment.
SATVI is seeking applications for a Project Manager who will manage clinical research projects within SATVI. NOW CLOSED
SATVI researchers Dr Anele Gele, Professors Tom scriba, Mark Hatherill and Associate Professor Elisa Nemes have co authored a research article titled: "Postnatal expansion, maturation and functionality of MR1T cells in humans" appearing in the Frontiers in Immunology journal.
SATVI researchers have published an article titled: "Multidimensional analyses reveal modulation of adaptive and innate immune subsets by tuberculosis vaccines" appearing in the Nature Communications Biology journal.